Download:
pdf |
pdfOMB No. 3117-0016/USITC No. 11-1-2934; Expiration Date: 6/30/2011
(No response is required if currently valid OMB control number is not displayed)
U.S. PRODUCERS’ QUESTIONNAIRE
GLYCINE FROM CHINA
This questionnaire must be received by the Commission by no later than April 27, 2011
See page 4 of the Instruction Booklet for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its review of the antidumping duty order concerning glycine from China (Inv. No. 731-TA-718 (Third
Review)). The information requested in the questionnaire is requested under the authority of the Tariff Act of 1930, title
VII. This report is mandatory and failure to reply as directed can result in a subpoena or other order to compel
the submission of records or information in your possession (19 U.S.C. § 1333(a)).
Name of firm
Address
City
State
Zip Code
World Wide Web address
Has your firm produced glycine (as defined in the instruction booklet) at any time since January 1, 2005?
NO
(Sign the certification below and promptly return only this page of the questionnaire to the Commission)
YES
(Read the instruction booklet carefully, complete all parts of the questionnaire, and return the entire
questionnaire to the Commission so as to be received by the date indicated above)
CERTIFICATION
I certify that the information herein supplied in response to this questionnaire is complete and correct to the best of my knowledge
and belief and understand that the information submitted is subject to audit and verification by the Commission.
By means of this certification I also grant consent for the Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout this review in any other import-injury proceedings or reviews
conducted by the Commission on the same or similar merchandise.
I acknowledge that information submitted in this questionnaire response and throughout this review may be used by the
Commission, its employees, and contract personnel who are acting in the capacity of Commission employees, for developing or
maintaining the records of this review or related proceedings for which this information is submitted, or in internal audits and
proceedings relating to the programs and operations of the Commission pursuant to 5 U.S.C. Appendix 3. I understand that all
contract personnel will sign non-disclosure agreements.
Name of Authorized Official
Title of Authorized Official
Phone: (
Date
)
Signature
E-mail address
Fax (
)
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 2
PART I.—GENERAL INFORMATION
The questions in this questionnaire have been reviewed with market participants to ensure that issues of
concern are adequately addressed and that data requests are sufficient, meaningful, and as limited as
possible. Public reporting burden for this questionnaire is estimated to average 50 hours per response,
including the time for reviewing instructions, searching existing data sources, gathering the data needed,
and completing and reviewing the questionnaire. Send comments regarding the accuracy of this burden
estimate or any other aspect of this collection of information, including suggestions for reducing the
burden, to the Office of Investigations, U.S. International Trade Commission, 500 E Street, SW,
Washington, DC 20436.
I-1a.
OMB statistics.--Please report below the actual number of hours required and the cost to your
firm of preparing the reply to this questionnaire and completing the form.
hours
dollars
I-1b.
OMB feedback.--We are interested in any comments you may have for improving this
questionnaire in general or the clarity of specific questions. Please attach such comments to your
response or send them to the above address.
I-2.
Establishments covered.--Provide the name and address of establishment(s) covered by this
questionnaire (see page 3 of the instruction booklet for reporting guidelines). If your firm is
publicly traded, please specify the stock exchange and trading symbol.
I-3.
Position regarding continuation of order.--Do you support or oppose continuation of the
antidumping duty order currently in place for glycine from China?
China
Support
Oppose
Take no position
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 3
PART I.--GENERAL INFORMATION--Continued
I-4.
Ownership.--Is your firm owned, in whole or in part, by any other firm?
No
Yes--List the following information.
Firm name
I-5.
I-6.
Address
Extent of ownership
Related SUBJECT importers/exporters.--Does your firm have any related firms, either
domestic or foreign, that are engaged in importing glycine from China into the United States or
that are engaged in exporting glycine from China to the United States?
No
Yes--List the following information.
Firm name
Address
Affiliation
Related NONSUBJECT importers/exporters.--Does your firm have any related firms, either
domestic or foreign, that are engaged in importing glycine from countries other than China
into the United States or that are engaged in exporting glycine from countries other than China to
the United States?
No
Yes--List the following information.
Firm name and country
Address
Affiliation
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 4
PART I.--GENERAL INFORMATION--Continued
I-7.
I-8.
Related producers.--Does your firm have any related firms, either domestic or foreign, that are
engaged in the production of glycine?
No
Yes--List the following information.
Firm name
Address
Affiliation
Business plan.--In Parts II and IV of this questionnaire we request a copy of your company’s
business plan. Does your company or any related firm have a business plan or any internal
documents that describe, discuss, or analyze expected market conditions for glycine?
No
Yes--Please provide the requested documents. If you are not providing the
requested documents, please explain why not.
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 5
PART II.—TRADE AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Stefania Pozzi Porter (202205-3177, [email protected]). Supply all data requested on a calendar-year basis.
II-1.
Please identify the individual to be contacted regarding the confidential information requested in
part II.
Name and title:
Please indicate the manner by which Commission staff may contact the individual responsible for
part II with questions regarding the submitted confidential information.
E-mail:
Fax: (
II-2.
Telephone: (
)
)
Changes in operations.--Please indicate whether your firm has experienced any of the following
changes in relation to the production of glycine since January 1, 2005.
(check as many as appropriate)
plant openings ..........................
plant closings ............................
relocations ................................
expansions ................................
acquisitions ...............................
consolidations ...........................
prolonged shutdowns or
production curtailments .................
revised labor agreements ..........
other (e.g., technology) ............
(please describe)
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 6
PART II.—TRADE AND RELATED INFORMATION--Continued
II-3.
Anticipated changes in operations.--Does your firm anticipate any changes in the character of
your operations or organization (as noted above) relating to the production of glycine in the
future?
No
II-4.
Yes--Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation that address this
issue. Include in your response a specific projection of your firm’s
capacity to produce glycine (in 1,000 pounds) for 2011 and 2012.
Anticipated changes in operations in the event the order is revoked.--Would your firm
anticipate any changes in the character of your operations or organization (as noted above)
relating to the production of glycine in the future if the antidumping duty order on glycine from
China were to be revoked?
No
Yes--Supply details as to the time, nature, and significance of such changes,
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation that address this
issue. Include in your response a specific projection of your firm’s
capacity to produce glycine (in 1,000 pounds) for 2011 and 2012.
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 7
PART II.—TRADE AND RELATED INFORMATION--Continued
II-5.
Same equipment, machinery, and workers.--Has your firm since 2005 produced, or does your
firm anticipate producing in the future, other products on the same equipment and machinery
used in the production of glycine and/or using the same production and related workers employed
to produce glycine?
No
Yes--List the following information and report your firm’s combined
production capacity and production of these products and glycine in
the periods indicated.
Product
Period
Basis for allocation of capacity and
employment data (indicate if different)
(Quantity in 1,000 pounds)
Item
2005
2006
2007
2008
2009
2010
Overall Production Capacity
Production of:
Glycine
Other product 1
Other product 2
II-6.
Constraints on production.--Please describe the constraint(s) that set the limit(s) on your
production capacity.
II-7.
Production shifting.--Is your firm able to switch production between glycine and other products
in response to a relative change in the price of glycine vis-a-vis the price of other products, using
the same equipment and/or labor?
No
Yes--Please identify the other products, the approximate time and cost
involved in switching, and the minimum relative price change required
for your firm to switch production to or from glycine.
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 8
PART II.—TRADE AND RELATED INFORMATION--Continued
II-8.
Trade data.--Report your firm’s production capacity, production, shipments, inventories, and
employment related to the production of glycine in your U.S. establishment(s) during the
specified periods. (See definitions in the instruction booklet.)
Quantity (in 1,000 pounds) and value (in $1,000)
Calendar year
Item
2005
2006
2007
2008
2009
2010
1
Average production capacity
(quantity) (A)
Beginning-of-period inventories
(quantity) (B)
Production (quantity) (C)
U.S. shipments:
Commercial shipments:
quantity (D)
value (E)
2
Internal consumption:
quantity (F)
value (G)
Transfers to related firms:2
quantity (H)
value (I)
Export shipments:3
quantity (J)
value (K)
End-of-period inventories
(quantity) (L)
Channels of distribution:
U.S. shipments to distributors
(quantity) (M)
U.S. shipments to end users
(quantity) (N)
Employment data:
Average number of PRWs
(number) (O)
Hours worked by PRWs
(1,000 hours) (P)
Wages paid to PRWs (value)
(Q)
1
The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate
production capacity, and explain any changes in reported capacity (use additional pages as
necessary).
2
Internal consumption and transfers to related firms should be valued at fair market value. In the
event that you use a different basis for valuing these transactions, please specify that basis (e.g., cost,
cost plus, etc.) and provide value data using that basis for each of the periods noted above:
3
Identify your principal export markets:
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 9
PART II.—TRADE AND RELATED INFORMATION--Continued
II-9.
Reconciliation of trade data.--
(a)
Please note that the quantities reported in question II-8 should reconcile as follows in
each period (i.e., in each column):
Reconciliation
B+C–D–F–H–J=L
D+F+H=M+N
(b)
Do these data reconcile?
explain
Do these data reconcile?
explain
Yes
No--Please
Yes
No--Please
Please note that the quantities reported for end-of-period inventories should equal the
beginning-of-period inventories reported in the subsequent calendar year (i.e., line L of
year 2005 should equal line B of year 2006). Do these data reconcile for each adjacent
calendar year?
Yes.
No--Please explain.
II-10.
Transfers to related firms.--If you reported transfers to related firms in question II-8, please
indicate the nature of the relationship between your firm and the related firms (e.g., joint venture,
wholly owned subsidiary), whether the transfers were priced at market value or by a non-market
formula, whether your firm retained marketing rights to all transfers, and whether the related
firms also processed inputs from sources other than your firm.
II-11.
Please indicate which production process your firm uses to produce glycine. (Check all that
apply.)
Hydrogen cyanide (“HCN”) process -- (This process uses formaldehyde, hydrogen cyanide,
anhydrous ammonia, sodium hydroxide, and sulfuric acid as raw material inputs and/or catalysts
to produce glycine. Sodium glycinate is a distinct intermediate product in this process.)
Monochloracetic acid (“MCA”) process -- (This process uses monochloroacetic acid,
anhydrous ammonia, and hexamethyleneteramine (also known as hexamine) as raw material
inputs and/or catalysts to produce glycine. Sodium glycinate is not an intermediate product in
this production process.)
Other--Please describe:
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 10
PART II.—TRADE AND RELATED INFORMATION--Continued
II-12.
Purchases.--Other than direct imports, has your firm otherwise purchased glycine since January
1, 2005? (See definitions in the instruction booklet.)
No
Yes-- Please indicate the reasons for your purchases (if your reasons differ by
source, please elaborate) and report the quantity and value of such
purchases below for the specified periods
Reasons:
(Quantity in 1,000 pounds, value in $1,000)
Item
2005
2006
2007
2008
2009
2010
PURCHASES FROM U.S.
IMPORTERS1 OF GLYCINE FROM.—
China:
quantity
value
All other countries:
quantity
value
PURCHASES FROM DOMESTIC
2
PRODUCERS:
quantity
value
PURCHASES FROM OTHER
SOURCES:
quantity
Value
1
Please list the name of the importer(s) from which you purchased this product. If your suppliers differ by
source, please identify the source for each listed supplier.
2
Please list the name of the domestic producer(s) from which you purchased this product.
II-13.
Toll production.--Since January 1, 2005, has your firm been involved in a toll agreement (see
definition in the instruction booklet) regarding the production of glycine?
No
II-14.
Yes--Name firm(s):
.
FTZ.--Does your firm produce glycine in a foreign trade zone (FTZ)?
No
Yes--Identify FTZ(s):
.
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 11
PART II.—TRADE AND RELATED INFORMATION--Continued
II-15.
Direct imports.--Since January 1, 2005, has your firm imported glycine?
No
Yes--COMPLETE AND RETURN A U.S. IMPORTERS’
QUESTIONNAIRE
II-16. Shipments by grade.—Please report the quantity of your firm’s 2010 U.S shipments by grade of
glycine (based on the actual quality of the glycine, not the market to which it is sold).
U.S. Shipments
Product
Quantity (in 1,000 pounds)
Pharmaceutical grade
USP grade
Technical grade
Other grade
II-17.
Effect of order.--Describe the significance of the existing antidumping duty order covering
imports of glycine from China in terms of its effect on your firm’s production capacity,
production, U.S. shipments, inventories, purchases, employment, revenues, costs, profits, cash
flow, capital expenditures, research and development expenditures, and asset values. You may
wish to compare your firm’s operations before and after the imposition of the order.
II-18.
Likely effect of revocation of order.--Would your firm anticipate any changes in its production
capacity, production, U.S. shipments, inventories, purchases, employment, revenues, costs,
profits, cash flow, capital expenditures, research and development expenditures, or asset values
relating to the production of glycine in the future if the antidumping duty order on glycine from
China were to be revoked?
No
Yes--Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation for any trends or
projections you may provide.
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 12
PART III.—FINANCIAL INFORMATION
Address questions on this part of the questionnaire to Charles Yost (202-205-3432,
[email protected]).
III-1.
Please identify the individual to be contacted regarding the confidential information requested in
part III?
Name and title:
Please indicate the manner by which Commission staff may contact the individual responsible for
part III with questions regarding the submitted confidential information.
E-mail:
Fax: (
Telephone: (
)
)
III-2. General guidance:--Financial data are requested on a product-line basis; the product is glycine, as
defined in the instruction booklet. Inputs your firm receives from affiliates to produce glycine
should be stated at cost (i.e., intra-firm profits eliminated, see question III-7) while transfers of
glycine to related affiliates should be stated at fair market value. Please report all sales on an
f.o.b. basis. Total sales in this section should equal total shipments plus exports in Part II, page 8
(trade data) of this questionnaire. PLEASE REPORT ALL FINANCIAL DATA ON A
CALENDAR YEAR BASIS.
III-3.
Accounting system.--Briefly describe your financial accounting system.
a) When does your fiscal year end (month and day)?
;.
b) Describe the lowest level of operations (e.g., plant, division, company-wide) for which
financial statements are prepared that include subject merchandise:
c) Does your firm prepare profit/loss statements for the subject merchandise:
Yes
No
d) How often did your firm (or parent company) prepare financial statements (including annual
reports, 10Ks)? Please check relevant items below.
Audited,
unaudited,
annual reports,
10Ks,
10 Qs,
Monthly,
quarterly,
semi-annually,
annually
e) Accounting basis:
GAAP,
cash,
or
other comprehensive (specify)
tax,
Note: The Commission may request that your company submit copies of its financial statements, including internal
profit-and-loss statements for the division or product group that includes glycine, as well as those statements and
worksheets used to compile data for your firm’s questionnaire response.
III-4.
Cost accounting system.--Briefly describe your cost accounting system (e.g., standard cost, job
order cost, etc.).
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 13
PART III.—FINANCIAL INFORMATION--Continued
III-5.
Allocation basis.-Briefly describe your allocation basis, if any, for COGS, SG&A, and interest
expense and other income and expenses.
III-6.
Other products.--Please list any other products you produced in the facilities in which you
produced glycine, and provide the share of net sales accounted for by these other products in your
most recent fiscal year:
Products
Share of sales
III-7a. Raw materials from related firms.--Does your company receive inputs (raw materials, labor,
energy, or any other services) used in the production of glycine from any related company?
Yes--Continue to question III-7b below.
No--Continue to question III-7c below.
III-7b. Inputs from related firms.--In the space provided below, identify the inputs used in the
production of glycine that your firm receives from related parties whose financial statements are
consolidated with the financial statements of your firm.
Input
Related party
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 14
PART III.—FINANCIAL INFORMATION--Continued
III-7c. Inputs from related firms at cost.--All intercompany profit on inputs purchased from related
parties should be eliminated from the costs reported to the Commission in question III-10 (i.e.,
costs reported in question III-10, to the extent that they reflect inputs purchased from related
parties, should only reflect the related party’s cost and not include an associated profit
component). Reasonable methods for determining and eliminating the associated profit on inputs
purchased from related parties are acceptable.
Has your firm complied with the Commission’s instructions regarding costs associated with
inputs purchased from related parties?
Yes
III-8.
No—Please contact Charles Yost (202-205-3432, [email protected]).
Nonrecurring charges.--For each annual period for which financial results are reported in
question III-10, please indicate in the schedule below the specific nonrecurring charges, the
particular expense/cost line items from question III-10 where the associated charges are included,
a brief description of the charges, and the associated values (in $1,000). Nonrecurring charges
would include, but are not limited to, items such as asset write-offs and accelerated depreciation
due to restructuring of the company’s glycine operations.
Calendar years ended-Item
2005
2006
2007
2008
2009
2010
Non-recurring charges: In the far left column please provide a brief description of each nonrecurring charge
and indicate the particular expense/cost line item where the associated charge is included in question III-10.
1.
2.
3.
4.
5.
6.
7.
III-9.
By-products.—For each annual period for which financial results are reported in question III-10,
please deduct the net sales value on a f.o.b. basis of the by-products (salt cake or other, for
example) that your firm recovered.
Please identify the by-products that your firm recovered and sold:
.
Please report the net sales value f.o.b. that was deducted here for the six most recently completed
calendar years:
2005: $
2006: $
2007: $
2008:$
2009: $
2010: $
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 15
PART III.—FINANCIAL INFORMATION--Continued
III-10. Operations on glycine.--Report the revenue and related cost information requested below on the
glycine operations of your U.S. establishment(s).1 Do not report resales of purchased glycine.
Note that internal consumption and transfers to related firms must be valued at fair market value
and purchases from related firms must be at cost.2 Provide data on a calendar year basis for the
six most recently completed years in chronological order from left to right. If your firm was
involved in tolling operations (either as the toller or as the tollee) please contact Charles
Yost (202-205-3432, [email protected]) before completing this section of the
questionnaire.
Quantity (in 1,000 pounds) and value (in $1,000)
Item
Net sales quantities:
Commercial sales
2005
2006
2007
2008
2009
2010
3
Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials, net of by-products
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
Continued Dumping and Subsidy Offset Act
5
funds received
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1
Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please eliminate any profits or (losses) on inputs from related firms pursuant to question III-7.
Less discounts, returns, allowances, and prepaid freight. The total quantities and values should approximate the corresponding
total shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with sales, internal consumption and transfers to related firms.
5
Please report funds received under this act in the period(s) in which they were received. Do not report these funds as an offset to
operating expenses.
2
3
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 16
PART III.—FINANCIAL INFORMATION--Continued
III-11. Asset values.--Report the total assets associated with the production, warehousing, and sale of
glycine. If your firm does not maintain some or all of the specific asset data in the normal course of
business, please estimate it based upon some rational method (such as production, sales, or costs) that is
consistent with your cost allocations in the previous question. Your finished goods inventory value
should reconcile with the inventory quantity data reported in Part II. Provide data as of the end of your
six most recently completed fiscal years in chronological order from left to right.
Item
2006
2005
Value (in $1,000)
2007
2008
2009
2010
ASSETS associated with the
production, warehousing, and sale of
product:
1. Current assets:
A. Cash and equivalents
B. Accounts receivable, net
C. Finished goods inventories
D. All other (describe:
)
E. Total current assets (lines
1.A. through 1.D.)
2. Property, plant, and equipment
A. Original cost of property,
plant, and equipment
B. Less: Accumulated
depreciation
C. Equals: Book value of
property, plant, and
equipment
3. Other (describe:
)
4. Total assets (lines 1.E., 2.C.,
and 3)
III-12. Capital expenditures and research and development expenses.--Report your firm’s capital
expenditures and research and development expenses on glycine. Provide data on a calendar year
basis for the six most recently completed years in chronological order from left to right.
Item
Capital expenditures
Research and
development expenses
2005
2006
Value (in $1,000)
Calendar year
2007
2008
2009
2010
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 17
PART IV.--PRICING AND MARKET FACTORS
Further information on this part of the questionnaire can be obtained from Aimee Larsen (202-205-3179,
[email protected]).
IV-1.
Please identify the individual to be contacted regarding the confidential information requested in
part IV?
Name and title:
Please indicate the manner by which Commission staff may contact the individual responsible for
part IV with questions regarding the submitted confidential information.
E-mail:
Fax: (
Telephone: (
)
)
PRICE DATA
This section requests quarterly quantity and value data, f.o.b. your U.S. point of shipment, for your
commercial shipments to unrelated U.S. customers since 2005 of the following products produced by
your firm.
Product 1.-- Pharmaceutical-grade glycine - A white, odorless, crystalline powder with a sweet
taste, having an assay (glycine content) of 98.5 percent to 101.5 percent (dry basis),
and with no more than 70 ppm chloride, no more than 65 ppm sulfate, and no more
than 10 ppm heavy metals.
Product 2.-- USP-grade glycine - A white, odorless, crystalline powder with a sweet taste,
having an assay (glycine content) of 98.5 percent to 101.5 percent (dry basis), and
with no more than 70 ppm chloride, no more than 65 ppm sulfate, no more than 20
ppm heavy metals, and not otherwise qualifying as pharmaceutical-grade glycine.
Product 3.--Technical-grade glycine - A white, off-white, or slightly yellow crystalline powder,
having an assay (glycine content) of 98.5 percent to 101.5 percent (dry basis), with
no more than 200 ppm sulfates, and not otherwise qualifying as USP-grade glycine.
Note.—The pricing product data should reflect the end use for which the glycine in question is sold. The
purity requirements listed for each pricing product reflect minimum purity requirements for end users in
those markets. Any glycine that could be sold into a higher purity end use but is not should be recorded
as a sale to the market into which it is sold. For example, if a producer produces glycine meeting the
specifications for use in deodorant applications (USP grade) but sells that product for metal complexing
(technical grade), that sale should be recorded as a technical grade sale.
Please note that total dollar values should be f.o.b., U.S. point of shipment and should not include
U.S.-inland transportation costs. Total dollar values should reflect the final net amount paid to you
(i.e., should be net of all deductions for discounts or rebates). See instruction booklet.
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 18
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-2.
Pricing data.--Report below the quarterly price data1 for pricing products2 produced and sold by
your firm.
Period of shipment
(Quantity in pounds, value in dollars)
Product 1
Product 2
Quantity
Value
Quantity
Value
Product 3
Quantity
Value
2005:
January-March
April-June
July-September
October-December
2006:
January-March
April-June
July-September
October-December
2007:
January-March
April-June
July-September
October-December
2008:
January-March
April-June
July-September
October-December
2009:
January-March
April-June
July-September
October-December
2010:
January-March
April-June
July-September
October-December
1
Net values (i.e., gross sales values less all discounts, allowances, rebates, prepaid freight, and the value of
returned goods), f.o.b. your U.S. point of shipment.
2
Pricing product definitions are provided on the first page of Part IV.
Note.--If your product does not exactly meet the product specifications but is competitive with the specified product,
provide a description of your product:
Product 1:
Product 2:
Product 3:
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 19
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-3. Price setting.-- How does your firm determine the prices that it charges for sales of glycine
(check all that apply)? If your firm issues price lists, please include a copy of a recent price list
with your submission. If your price list is large, please only submit some sample pages.
Transaction by transaction
Contracts
Set price lists
Other--Please describe:
IV-4.
Discount policy.-- Please indicate and describe your firm’s discount policies (check all that
apply).
Quantity discounts
Annual total volume discounts
No discounts
Other--Please describe:
IV-5.
IV-6.
Pricing terms for glycine.-(a)
What are your firm’s typical sales terms for its U.S.-produced glycine (e.g., 2/10 net 30
days)?
.
(b)
On what basis are your prices of domestic glycine usually quoted? (check one)
F.o.b.--Please specify point:
Delivered
Contract versus spot.--Approximately what share of your firm’s sales of its U.S.-produced
glycine in 2010 were on a (1) long-term contract basis (multiple deliveries for more than
12 months), (2) short-term contract basis (multiple deliveries up to and including 12 months), and
(3) spot sales basis (for a single delivery)?
Type of sale
Long-term contracts
Short-term contracts
Spot sales
Share of sales (percent)
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 20
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-7.
IV-8.
IV-9.
Long-term contract provisions.--If you sell on a long-term contract basis, please answer the
following questions with respect to provisions of a typical long-term contract.
(a)
What is the average duration of a contract?
(b)
Can prices be renegotiated during the contract period?
(c)
Does the contract fix quantity, price, or both?
(d)
Does the contract have a meet or release provision?
Yes
Quantity
No
Price
Yes
Both
No
Short-term contract provisions.--If you sell on a short-term contract basis, please answer the
following questions with respect to provisions of a typical short-term contract.
(a)
What is the average duration of a contract?
(b)
Can prices be renegotiated during the contract period?
(c)
Does the contract fix quantity, price, or both?
(d)
Does the contract have a meet or release provision?
Yes
Quantity
No
Price
Yes
Both
No
Lead times.--What is the average lead time between a customer’s order and the date of delivery
for your firm’s sales of your U.S.-produced glycine?
Source
Share of sales in 2010
Lead time
From inventory
Produced to order
Total
100 %
IV-10. Shipping information.-(a)
What is the approximate percentage of the total delivered cost of glycine that is
accounted for by U.S. inland transportation costs?
percent.
(b)
Who generally arranges the transportation to your customers’ locations? (check one)
your firm or
purchaser
(c)
What proportion of your sales are delivered within 100 miles of your production facility?
percent. Within 101 to 1,000 miles?
percent. Over 1,000 miles?
percent.
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 21
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-11. Geographical shipments.-- What is the geographic market area in the United States served by
your firm’s glycine? (check all that apply)
Geographic area
if applicable
Northeast.–CT, ME, MA, NH, NJ, NY, PA, RI, and VT.
Midwest.–IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, and WI.
Southeast.–AL, DE, DC, FL, GA, KY, MD, MS, NC, SC, TN, VA, and WV.
Central Southwest.–AR, LA, OK, and TX.
Mountains.–AZ, CO, ID, MT, NV, NM, UT, and WY.
Pacific Coast.–CA, OR, and WA.
Other.–All other markets in the United States not previously listed, including AK, HI,
PR, VI, among others.
IV-12. Changes in end uses.--Have there been any changes in the end uses of glycine since 2005?
No
Yes--Please describe.
IV-13. Anticipated changes in end uses.--Do you anticipate any changes in terms of the end uses of
glycine in the future?
No
Yes--Please describe and identify the time period
IV-14. Pharmaceutical grade glycine.—Please describe and comment on the market for pharmaceutical
grade glycine. How is it different from the market for USP grade glycine? What are the barriers
to entry into this market? What is the role of government regulation in setting production
standards?
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 22
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-15 Substitutes.—Are there any nonsubject products that may be substituted for glycine?
No
Substitute
product
Yes—Please fill in the following table.
Description of
applications and end Have changes in the prices of this substitute affected
uses in which this
the price of glycine since January 1, 2005?
substitute can be used
Please explain.
1.
No
Yes
2.
No
Yes
3.
No
Yes
IV-16. Changes in substitutes.--Have there been any changes in the number or types of products that
can be substituted for glycine since 2005?
No
Yes--Please explain.
IV-17. Anticipated changes in substitutes.--Do you anticipate any changes in terms of the
substitutability of other products for glycine in the future?
No
Yes--Please describe.
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 23
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-18. Raw materials.—
(a)
To what extent have changes in the prices of raw materials affected your firm’s selling
prices for glycine since 2005?
(b)
Do you anticipated changes in your raw material costs in the foreseeable future?
No
Yes--Please explain.
IV-19. Changes in factors affecting supply.--Have any changes occurred in any other factors affecting
supply (e.g., changes in availability or prices of energy or labor; transportation conditions;
production capacity and/or methods of production; technology; export markets; or alternative
production opportunities) that affected the availability of U.S.-produced glycine in the U.S.
market since 2005?
No
Yes--Please note the time period(s) of any such changes, the factors(s)
involved, and the impact such changes had on your shipment volumes
and prices.
IV-20. Availability of supply (U.S.-produced).-(a)
Do you anticipate any changes in terms of the availability of U.S.-produced glycine in the
U.S. market in the future?
Increase
(b)
No change
If you anticipate changes in supply, please explain.
Decrease
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 24
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-21. Availability of supply (nonsubject).--Has the availability of NONSUBJECT glycine (i.e.,
glycine imported from countries other than China) changed since 2005?
No
Yes--Please explain.
IV-22. Export constraints.--Can your firm shift its sales of glycine between the U.S. market and
alternative country markets?
No
Yes
Please describe any contracts, other sales arrangements, or other constraints that would prevent or
retard your firm from shifting glycine between the U.S. and alternative country markets within a
12-month period.
IV-23. Product changes.--Have there been any significant changes in the product range, product mix, or
marketing of glycine since 2005?
No
Yes--Please describe and quantify if possible for each grade of glycine for
which you are answering “Yes.”
IV-24. Anticipated product changes.--Do you anticipate any changes in terms of the product range,
product mix, or marketing of glycine in the future?
No
Yes--Please identify, including the time period.
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 25
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-25. Demand trends.-(a)
How has the demand within the United States for glycine changed since January 1, 2005?
What principal factors affect changes in demand?
Increased
(b)
No Change
Decreased
Fluctuated
How has the demand outside the United States (if known) for glycine changed since
January 1, 2005? What principal factors affect changes in demand?
Increased
No Change
Decreased
Fluctuated
IV-26. Anticipated demand trends.—
(a)
How do you anticipate demand will change within the United States for glycine in the
future? What principal factors will affect these changes in demand?
Increase
(b)
No Change
Decrease
Fluctuate
How do you anticipate demand will change outside the United States for glycine in the
future? What principal factors will affect these changes in demand?
Increase
No Change
Decrease
Fluctuate
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 26
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-27. Conditions of competition.-(a)
Is the glycine market subject to business cycles or conditions of competition other than
the changes in the overall economy?
No
(b)
Yes--Please explain and estimate the duration of any such cycle.
Have the business cycles or conditions of competition for glycine changed since 2005?
No
Yes--Please explain any such changes.
IV-28. Supply constraints.--Has your firm refused, declined, or been unable to supply glycine since
January 1, 2005? (Examples include placing customers on allocation or “controlled order entry,”
declining to accept new customers or renew existing customers, delivering less than the quantity
promised, unable to meet timely shipment commitments, etc.).
No
Yes-- Please note and document the time period(s) (i.e., month and year), the
customer involved, the amount and type of product involved; and the
reason for the allocation.
IV-29. Price comparisons.—How do the market prices of glycine in the U.S. compare with non-U.S.
markets, if known? Provide specific information as to time periods and regions for any price
comparisons.
U.S. market prices are higher
Market price is the same
U.S. market prices are lower
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 27
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-30. Market studies.--Please provide as a separate attachment to this request any studies, surveys, etc.
that you are aware of that quantify and/or otherwise discuss glycine supply (including production
capacity and capacity utilization) and demand in (1) the United States, (2) each of the other major
producing/consuming countries, including China, and (3) the world as a whole. Of particular
interest is such data from 2005 to the present and forecasts for the future.
IV-31. Barriers to trade.--Are your exports of glycine subject to any tariff or non-tariff barriers to trade
in other countries?
No
Yes--Please list the countries and describe any such barriers and any
significant changes in such barriers that have occurred since 2005, or
that are expected to occur in the future.
IV-32. Interchangeability.--Is glycine produced in the United States and in other countries
interchangeable (i.e., can they physically be used in the same applications)? Please indicate
below, using “A” to indicate that the products from a specified country-pair are always
interchangeable, “F” to indicate that the products are frequently interchangeable, “S” to indicate
that the products are sometimes interchangeable, “N” to indicate that the products are never
interchangeable, and “0” to indicate no familiarity with products from a specified country-pair.1
Country-pair
China
Other countries
United States
China
1
For any country-pair producing glycine that is sometimes or never interchangeable, please explain
the factors that limit or preclude interchangeable use:
Business Proprietary
U.S. Producers’ Questionnaire - Glycine
Page 28
PART IV.--PRICING AND MARKET FACTORS--Continued
IV-33. Factors other than price.--Are differences other than price (i.e., quality, availability,
transportation network, product range, technical support, etc.) between glycine produced in the
United States and in other countries a significant factor in your firm’s sales of the products?
Please indicate below, using “A” to indicate that such differences are always significant, “F” to
indicate that such differences are frequently significant, “S” to indicate that such differences are
sometimes significant, “N” to indicate that such differences are never significant, and “0” to
indicate no familiarity with products from a specified country-pair.1
Country-pair
China
Other countries
United States
China
1
For any country-pair for which factors other than price always or frequently are a significant factor in
your firm’s sales of glycine, identify the country-pair and report the advantages or disadvantages imparted
by such factors:
| File Type | application/pdf |
| File Title | T:\Active Cases\Glycine\Questionnaires\OMB submission form add.wpd |
| Author | fred.ruggles |
| File Modified | 2011-04-12 |
| File Created | 2011-04-12 |